Literature DB >> 16343686

Profiling of resource use variation among six diseases treated at 82 Japanese special functioning hospitals, based on administrative data.

Kazuaki Kuwabara1, Yuichi Imanaka, Shinya Matsuda, Kiyohide Fushimi, Hideki Hashimoto, Koichi B Ishikawa, Hiromasa Horiguchi.   

Abstract

BACKGROUND: Profiling treatment in Japanese hospitals has rarely been conducted systematically with an administrative database. The study aims to present descriptive statistics of medical profiling and to examine the sources of variation in resource used for six common diseases.
METHODS: Administrative records for 266,677 patients were analyzed to examine variation in length of stay (LOS) and total charge (TC) by hierarchical multiple linear regression for cases of ischemic stroke, ischemic heart disease (IHD), great vessel disease (GVD), respiratory neoplasm, gastric neoplasm and colonic neoplasm.
RESULTS: Average LOS and TC increased with disease severity and invasiveness of surgical procedure. The coefficient of determination of the full model was highest for LOS in IHD (0.432), and for TC that was highest in GVD (0.702). Among various variable sets examined, surgical procedures explained largest variance in resource use.
CONCLUSION: With a standardized database derived from claims data, wide audience of stakeholders in Japanese healthcare will be able to access the profiling of practice or disease variation concerned.

Entities:  

Mesh:

Year:  2005        PMID: 16343686     DOI: 10.1016/j.healthpol.2005.11.006

Source DB:  PubMed          Journal:  Health Policy        ISSN: 0168-8510            Impact factor:   2.980


  2 in total

1.  The association of the number of comorbidities and complications with length of stay, hospital mortality and LOS high outlier, based on administrative data.

Authors:  Kazuaki Kuwabara; Yuichi Imanaka; Shinya Matsuda; Kiyohide Fushimi; Hideki Hashimoto; Koichi B Ishikawa; Hiromasa Horiguchi; Kenshi Hayashida; Kenji Fujimori
Journal:  Environ Health Prev Med       Date:  2008-03-29       Impact factor: 3.674

2.  Are we lacking economic evaluations in gastric cancer treatment?

Authors:  Alyson L Mahar; Abraham El-Sedfy; Savtaj S Brar; Ana Johnson; Natalie Coburn
Journal:  Pharmacoeconomics       Date:  2015-02       Impact factor: 4.981

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.